Jon Cuthbert

Repare Therapeutics (NASDAQ:RPTX) has entered into a definitive asset purchase agreement to sell its polymerase theta (Polθ) ATPase inhibitor, RP-3467, to Gilead Sciences (NASDAQ:GILD) for up to $30 million.

Agios Pharmaceuticals (NASDAQ:AGIO) announced today that the U.S. Food and Drug Administration (FDA) has approved AQVESME™ (mitapivat) for the treatment of anemia in adults with alpha- or beta-thalassemia.

The SEC has warned that crypto scammers are increasingly targeting retail investors through private group chats, using AI-driven impersonation and fake platforms to steal funds.

Presearch sold out its inaugural Node NFT auction in one day, raising over four million PRE tokens and signalling strong demand for its decentralised search network upgrade.

Amplify has launched two new ETFs tracking companies building stablecoin and tokenisation infrastructure as institutional interest in digital finance accelerates.

Matador Technologies has received regulatory approval to raise $58 million to expand its bitcoin treasury as it targets holding 1,000 BTC by 2026.

Cipher Mining has entered the United States’ largest wholesale power market by acquiring an Ohio data centre site to support bitcoin mining and high-performance computing expansion.

Alphabet is buying Intersect Power for $4.75 billion to secure electricity for expanding AI data centres, highlighting how control of energy has become critical in the AI race.

Kingsgate Consolidated (ASX:KCN) has secured a US$25 million standby loan facility with Nebari Natural Resources Credit Fund II.

High Peak Royalties (ASX:HPR) has completed the sale of its wholly owned subsidiary, Torrens Energy (SA).